$YCBD News

cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript

Full Transcript: cbdMD Q2 2026 Earnings Call

cbdMD Q2 EPS $(0.08) Misses $(0.05) Estimate, Sales $5.640M Beat $5.292M Estimate

cbdMD Shareholders Approve Potential Reverse Stock Split Of Up To 1-for-10

cbdMD Introduces Clinical Healthcare Channel

cbdMD, Inc. Q1 2026 Earnings Call Summary

cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ...

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

cbdMD shares are trading higher after the company reported better-than-expected Q1 financial results.

cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript

cbdMD Q1 Earnings Report: What Investors Need to Know

cbdMD Q1 EPS $(0.04) Beats $(0.06) Estimate, Sales $5.017M Beat $4.858M Estimate

Earnings Outlook For cbdMD

'Federal Agency Finalized Rule For CBD Medicare Coverage Pilot Program Weeks Ago, Key Hemp Stakeholder Says'- Marijuana Moment

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

cbdMD shares are trading lower. The company announced a distribution expansion for its Herbal Oasis THC-infused social seltzer through an expanded partnership with Morales Beverage Group.

cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum

cbdMD Expands Its Herbal Oasis THC-Infused Social Seltzer Through Partnership With Morales Beverage Group

cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways

cbdMD Announces Strategic Initiative To Integrate And Expand Its Regulatory Science, Safety, And Intellectual Property Assets To Establish A Differentiated Cannabinoid Compliance And Evidence Platform Aligned With Evolving Federal Healthcare Evaluation Frameworks, Including Emerging CMS And CMMI Innovation Initiatives